"Serum Albumin, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum albumin from humans. It is an essential carrier of both endogenous substances, such as fatty acids and BILIRUBIN, and of XENOBITOICS in the blood.
| Descriptor ID |
D000075462
|
| MeSH Number(s) |
D12.776.034.841.603 D12.776.124.727.906
|
| Concept/Terms |
Serum Albumin, Human- Serum Albumin, Human
- Albumin, Human Serum
- Human Serum Albumin
- Albumin Human
- Human, Albumin
- Human Albumin
- Albumin, Human
|
Below are MeSH descriptors whose meaning is more general than "Serum Albumin, Human".
Below are MeSH descriptors whose meaning is more specific than "Serum Albumin, Human".
This graph shows the total number of publications written about "Serum Albumin, Human" by people in this website by year, and whether "Serum Albumin, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serum Albumin, Human" by people in Profiles.
-
Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy. Oxid Med Cell Longev. 2021; 2021:6648199.
-
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 2019 05 11; 393(10184):1937-1947.
-
Homozygous Mutation in Human Serum Albumin and Its Implication on Thyroid Tests. Thyroid. 2018 06; 28(6):811-814.
-
Transcellular Pathways in Lymphatic Endothelial Cells Regulate Changes in Solute Transport by Fluid Stress. Circ Res. 2017 Apr 28; 120(9):1440-1452.
-
Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. Pract Radiat Oncol. 2017 May - Jun; 7(3):173-182.